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In a previous article Ruiter (1) recorded the
results of an analysis by means of histological
and histochemical technics of the fibrinoid
changes occurring in arteriolitis (vasculitis)
"allergica" cutis. It appeared that the protein
component of the "fibrinoid" material mainly
consisted of fibrin.
It must be assumed that in the deposition of
fibrin as fibrinoid in the vascular wall various
factors are of importance. As one of these, a
local increase in vascular permeability should
be considered. Ruiter observed the development
of an extensive argentophylic meshwork in and
around the wall of the affected vessels. It is
conceivable that this should be explained by
the alteration of connective-tissue ground-sub-
stance (polysaccharide-protein complexes) lead-
ing to the splitting-up of larger units of the
connective tissue ("fibres") into smaller units
("fibrils") on the one hand and to an increased
permeability of the subintimal basal mem-
brane forming part of this system on the other.
In addition alterations of the endothelial lin-
ing were frequently found. At the same time
the composition of the medium in which the
conversion of fibrinogen (or a derivative of this
protein?) into fibrin occurred probably has also
been of importance with regard to the deposi-
tion of the latter as fibrinoid in the vascular
lesions. Little is known about the composition
of this medium viz, the inflamed area in and
around the affected vessels, though tissue damage
and in particular disintegration of inflamm4ory
cells doubtlessly will have contributed enzymes
and thromboplastic substances to the lesions
concerned.
Probably other unknown or insufficiently
known factors will appear to play a role in the
formation of the vascular fibrinoid under dis-
cussion. Here we want to draw special attention
to a peculiar fraction of the blood plasma
demonstrable in our patients with "allergic"
arteriolitis of the skin, which may also have
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contributed to the deposition of fibrin in the
vascular wall in the form of fibrinoid.
Thomas ci at., (2, 3) found that, on the intrave-
nous injection of bacterial endotoxins into rabbits,
a protein-fraction could be demonstrated in the
heparinized plasma after an interval of a few
hours. At 4° C. this protein was precipitated from
the plasma as a cloudy substance, which again
dissolved at room temperature. A few hours later
the fraction had again disappeared from the
plasma. If 24 hours after the first injection a second
dose was given, a Sanarelli phenomenon occurred
and the fraction was again—and in higher quan-
tity—observed in the plasma. In these circum-
stances the protein fraction, which they believed
to be a polymerized form of fibrinogen, was
precipitated a.o. in the kidneys. The in vivo pre-
cipitation of this plasma fraction could be
markedly enhanced if certain mucoitin-polysul-
furic esters were injected intravenously shortly
after the appearance of the fraction in the blood.
Smith's studies (1957) (4) have especially contrib-
uted to the knowledge of the occurrence of such
a plasma fraction in human pathology. This
author observed a marked increase of this fraction
(heparin precipitable fraction = H.P.F.) in a
number of different diseases, such as neoplastic
diseases, acute bacterial infections and certain
"collagen" diseases (rheumatic fever, dermato-
myositis). In pregnancy elevated H.P.F. values
were also found, with a maximum level at delivery.
In collaboration with von Korif (5) he carried out
extensive studies on the nature of this heparin-
precipitable fraction in man. One of the conclu-
sions reached was that it is probably identical
with the plasma fractions found by Thomas ci at.
in rabbits. In their opinion both fractions are
closely related to or associated with fibrinogen.
Studies with the analytical ultracentrifuge at 2° C.
revealed this human H.P.F. to consist of two
components. The larger of the two was clottable
by thrombin, the other not.
METUOD5 AND MAtERIALS
Studies on the presence of H.P.F. in the plasma
were carried out on 15 patients who had various
clinical forms of "allergic" arteriolitis of the skin.
All the patients were free from fever (elevated
fibrinogen levels in pyrexial diseases!). At the
same time the liver-functions (low fibrinogen level
in liver diseases!) were studied. No abnormalities
were found. In addition all cases were studied for
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FIG. 1. Cold heparin precipitates. At the left
plasma from a healthy subject with only a trace
of precipitate. At the right plasma from a patient
with "allergic" arteriolitis of the skin with mark-
edly elevated H.P.F.
H. P. F. [vol. %]
cryoglobulins and macroglobulins (ultracentri -
fuge) with negative results. Since it appeared that
the heparin precipitable fraction was also present
in healthy individuals, though in low concentra-
tion, it was necessary to elaborate a quantitative
method for determining the II.P.F. values. We
used a hematoerit method. Hematocrits to which
'io ml heparinized plasma had been added were
allowed to remain for 16-18 hours at 4° C. Then
they were centrifuged for 10 minutes in a Christ K
III S refrigerated centrifuge at 2000 r.p.m. at 4° C.
This was followed by reading the height of the
precipitate.
In the majority of the cases distinctly increased
H.P.F. levels with a maximum value of 12 vol. %
(normally 1—14 vol. %) were found (fig. 1). Usu-
ally high H.P.F. levels returned to low and normal
values as recovery progressed (fig. 2). It appeared
thatthe H.P.F. levels in one and the same patient
were subject to marked fluctuation. The highest
levels were found at the onset of the disease
and at the beginning or shortly after recurrence
(fig. 3).
The question arises how far and in what way
H.P.F. may have participated in the deposition
of fibrinoid in the vascular lesions observed in
our cases. In the accompanying table the initial
H.P.F. values (at the onset of the disease or at
the time of a recurrence) are given for the
individual patients, together with the amount
of fibrinoid material observed in the histological
FIG. 2. Curve of H.P.F. values determined during the course of a case of the papulo-necrotic type.
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FIG. 3. Serial determination of II.P.F. values in a case of the hemorrhagic type showing various suc-
cessive recurrences.
sections. As a rule the latter was estimated on
the basis of several biopsies of fresh cutaneous
lesions. At the same time H.P.F. levels and
fibrinoid were determined simultaneously, if
possible.
A rough correlation between II.P.F. levels
and fibrinoid might be deduced from the data
reproduced in the accompanying table. Fresh
lesions showing distinct fibrinoid were associated
in all cases with high }I.P.F. levels in the blood
plasma. In eases showing only slight fibrinoid
changes, H.P.F. levels were low and, in two
patients (1 and 6) in whom various histological
examinations revealed no vascular fibrinoid,
repeated determinations showed normal or sub-
normal H.P.F. values. As demonstrated in
eases 3 and 4 however, elevated H.P.F. levels
are not necessarily associated with pronounced
vascular fibrinoid. We have the impression that
this phenomenon occurs from time to time
especially in the haemorrhagie type of arteriolitis
(vasculitis) "allergiea" eutis, a clinical variant
including among others rheumatic purpura and
purpura Sehoenleini. This problem will be dis-
cussed later.
The question as to what extent H.P.F. might
be responsible for the deposition of fibrinoid was
also considered by Smith. Our personal study was
limited to one syndrome, whereas the above-
mentioned author determined the H.P.F. levels
in various forms of "collagen" diseases. The
results obtained by this author were variable.
The low levels found in a few eases of visceral
lupus erythematosus and polyarteritis were re-
markable. Smith suggested the possibility that
in these diseases H.P.F. is subjected to continuous
depletion as the fibrinoid deposits characteristic
for these disorders are being laid down in various
organs. In this connection it should be remem-
bered that eases of "allergic" arteriolitis of the
skin in which the vascular lesions are mainly
limited to the skin itself have either a relative
short course or are—if they take a chronic
course—characterized by recurrences that are
followed by long-lasting symptom-free intervals
with low II.P.F. levels (see also fig. 3). It is
conceivable that in this manner the II.P.F.
depletion in "allergic" arteriolitis of the skin is
periodical, whereas it is continuous in the former
group of syndromes. At the same time Smith—
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who is rather critical with regard to the relation-
ship between H.P.F. and fibrinoid—draws atten-
tion to some conditions characterized by high
H.P.F. levels, such as bacterial meningitis, in
which autopsies do not commonly reveal exten-
sive fibrinoid lesions. However, it should be
stressed here that it must be assumed that H.P.F,
cannot be the exclusive cause of the deposition
of fibrinoid in vascular changes. As has been
pointed out, several factors may play a part in
these processes, among these an increase in
vascular permeability and the composition of
the medium in which the conversion of fibrinogen
(or related proteins?) into fibrin occurs. It is
conceivable that in a number of cases of the
hemorrhagic type of "allergic" arteriolitis of the
skin, in which, despite high H.P.F. levels, little
fibrinoid is found, the composition of this medium
has been partly responsible.
In his paper Smith draws attention to a number
of "abnormal" fibrinogens which have been
found especially in recent years and which show
several resemblances to H.P.F. It is noteworthy
that some of these have been described as attach-
ing themselves to suitable cell elements and tissue
substrates. Cryofibrinogen demonstrated by
Korst and Kratochvil (6) regularly produced
rouleaux formations of red blood cells. The same
phenomenon occurs when H.P.F. is added to
washed erythrocytes (Smith). Contractinogen
(Morrison) (7), reversibly cold insoluble like
H.P.F., was thought to be responsible for ag-
gregation and settling of red blood cells rather
than the more soluble clottable fractions. Ac-
cording to Smith H.P.F. may also represent a
polymer formed during the conversion of fibrino-
gen into fibrin resembling among others the
profibrin studied by Apitz. According to this
author (8) profibrin has a tendency to precipitate
against suitable substrates and is, in his opinion,
of importance in connection with the origin of
mural thrombi. One wonders if in view of these
observations the perivascular meshwork of the
"pathological" collagen-reticulin in arteriolitis
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(vasculitis) "allergica" cutis might be considered
as a substrate suitable for the deposition of
H.P.F. followed by or associated with conver-
sion of this protein into fibrin. If so H.P.F. might
be responsible in particular for the so-called
fibrinoid swelling of the connective tissue in and
around the vascular lesions.
As has been pointed out before, the in vivo
precipitation of H.P.F., according to Thomas
et al. is markedly enhanced in the presence of
various mucoitin-polysulfuric esters. Some
authors suggest, that in this way certain mucoitin
sulfates, released by injury of the connective
tissue ground substance, may play a role in the
formation of fibrinoid. Evidence for this is,
however, lacking.
su}IMAEv
The conditions which determine the deposition
of vascular fibrinoid in so-called allergic arterio-
litis (vaseulitis) of the skin are discussed. Among
the various factors playing a part, two are
considered of primary importance. The first is an
increased vascular permeability of the vessels
concerned. This condition, possibly resulting
from physieo-chemical changes of the subintimal
basement membrane, leads to infiltration of the
vascular wall and its immediate surroundings
with blood plasma proteins. The second is a
conversion of infiltrating fibrinogen or a fibrino-
gen-derivative into fibrin. Regarding this latter
factor special attention is drawn to a blood plasma
fraction (H.P.F.), probably a derivative of
fibrinogen, which precipitates from heparinized
plasma at 40 C. A semi-quantitative hematoerit
method is described for estimating H.P.F. levels
in blood plasma. Distinctly elevated levels of
this substance were found in the majority of
cases. The highest values were observed at the
onset of clinical manifestations in the primary
attack and recurrences. H.P.F. values usually
returned to normal as recovery progressed. In 13
patients (out of 15) the degree of vascular
fibrinoid in the lesions as seen histologically
roughly corresponded to the H.P.F.-values found
in the blood plasma. Possible reasons for some
discrepancies (2 eases) observed in this investiga-
tion are suggested. The question as to the extent
and the manner in which II.P.F. may contribute
to the formation of fibrinoid vascular changes is
considered.
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